Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis

Yuji Oba; Sumayya Anwer; Tinashe Maduke; Tarang Patel; Sofia Dias

doi:10.1002/14651858.CD013797.pub2

Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis

Yuji Oba^*, Sumayya Anwer, Tinashe Maduke, Tarang Patel, Sofia Dias

^*Corresponding author for this work

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Cochrane Database of Systematic Reviews
DOIs	https://doi.org/10.1002/14651858.CD013797.pub2
Publication status	Published - 21 Aug 2023

Bibliographical note

Access to Document

10.1002/14651858.CD013797.pub2

Accepted_Pdf_CD013797_2-9
© 2023 The Cochrane Collaboration. This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy.
Accepted author manuscript, 3.77 MBLicence: CC BY

Cite this

Oba, Y., Anwer, S., Maduke, T., Patel, T., & Dias, S. (2023). Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD013797.pub2

@article{039b7d5c2070499badaec04b2402bd1c,

title = "Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis",

author = "Yuji Oba and Sumayya Anwer and Tinashe Maduke and Tarang Patel and Sofia Dias",

note = "{\textcopyright} 2023 The Cochrane Collaboration. This is an author-produced version of the published paper. Uploaded in accordance with the University{\textquoteright}s Research Publications and Open Access policy. ",

year = "2023",

month = aug,

day = "21",

doi = "10.1002/14651858.CD013797.pub2",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "The Cochrane Collaboration",

}

Oba, Y, Anwer, S, Maduke, T, Patel, T & Dias, S 2023, 'Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis', Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD013797.pub2

Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis. / Oba, Yuji; Anwer, Sumayya; Maduke, Tinashe et al.
In: Cochrane Database of Systematic Reviews, 21.08.2023.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS

T2 - a systematic review and network meta-analysis

AU - Oba, Yuji

AU - Anwer, Sumayya

AU - Maduke, Tinashe

AU - Patel, Tarang

AU - Dias, Sofia

PY - 2023/8/21

Y1 - 2023/8/21

U2 - 10.1002/14651858.CD013797.pub2

DO - 10.1002/14651858.CD013797.pub2

M3 - Article

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Oba Y, Anwer S, Maduke T, Patel T, Dias S. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. 2023 Aug 21. doi: 10.1002/14651858.CD013797.pub2